Buys
Open market- Shares
- Avg price
- Total value
Innovative Cellular Therapeutics Holdings Ltd - 10%+ Owner at Lyell Immunopharma, Inc.
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- LYEL on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Innovative Cellular Therapeutics Holdings Ltd in Lyell Immunopharma, Inc.
Sells
Open market- Shares
- -20
- Avg price
- $13.72
- Total value
- -$274
Net
Past year- Shares
- -20
- Share %
- -100%
- Total value
- -$274
Reported holdings for Innovative Cellular Therapeutics Holdings Ltd in Lyell Immunopharma, Inc.
Form 4 holding
10%+ Owner
Lyell Immunopharma, Inc.
- Security class
- Common Stock
- Shares / value
- 2,857,480
- Estimated value
- $39,147,476
- Report date
- 17 Jul 2026
- Price
- $13.70
- Ownership
- Direct
Transaction history for Innovative Cellular Therapeutics Holdings Ltd in Lyell Immunopharma, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.